Nektar Therapeutics has appointed John Northcott to the newly-created position of senior vice president and chief commercial officer. John will also serve as a member of the Executive Committee reporting to president and chief executive officer, Howard W. Robin. Mr. Northcott has extensive commercial experience, including both pre-launch planning and on-market commercialization in oncology and other therapeutic areas. Most recently, he served as chief commercial officer of Pharmacyclics from ...